What is Tinnitus Heterogeneity? Heterogeneity is a word that signifies diversity. Tinnitus is considered to be heterogeneous, with many variations across people in the sounds people hear, and factors that change their tinnitus.
ATA presented "Vagus Nerve Stimulation - A New Treatment for Tinnitus?" on Tuesday evening. We want to share with you a video testimonial from Mark, an Indianapolis firefighter and veteran, who utilized vagus nerve stimulation. A copy of the full webinar recording will be available in the Member section at ATA.org within a few days.
See below for a short video testimonial from someone who utilized this experimental treatment. To learn more, don't miss ATA's Webinar "Vagus Nerve Stimulation - A New Treatment for Tinnitus?" Register today!
Melanie West, ATA Chair, Jinsheng Zhang, Ph.D., Chair of ATA's Scientific Advisory Committee and ATA board member, and Dr. Michael Robb, M.D., past ATA board member and current professional member, were recently interviewed by Energy Times and provided useful information on tinnitus.
LaGuinn Sherlock, Au.D. and Norma Mraz, Au.D., current directors on ATA's Board of Directors, and Dr. Michael Robb, MD, past ATA board member and current professional member, were recently interviewed by Reader's Digest and offered impactful information on tinnitus and treatment options.
The American Tinnitus Association Presents: "Cochlear Implants/Electric Stimulation; The Relationship to Tinnitus & Hyperacusis."
The deadline to register for non-members is Thursday, July 7. For ATA Members the deadline is Friday, July 8.